The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.
Market view
cefotaxime · Injection
1 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Cephalosporin Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- cefotaxime injection· in shortage
- ceftazidime, avibactam· 1 maker
- ceftobiprole medocaril sodium· 1 maker
- ceftolozane and tazobactam· 1 maker
- cefuroxime· 1 maker
- cefuroxime and dextrose· 1 maker
- zidebactam dihydrate and cefepime hydrochloride· 1 maker
- cefiderocol sulfate tosylate· 2 makers
- cefotetan· 2 makers
- cefotetan disodium· 2 makers
- ceftaroline fosamil· 2 makers
- cefuroxime sodium· 2 makers
Common questions
- Is Cefotaxime in shortage right now?
- Yes. FDA currently lists Cefotaxime in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.
- Who makes Cefotaxime?
- 1 company has marketed Cefotaxime in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)Feb 17, 2015
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.